These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26485712)

  • 1. High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.
    Chen L; Yang L; Qiao F; Hu X; Li S; Yao L; Yang XL; Shao ZM
    PLoS One; 2015; 10(10):e0140572. PubMed ID: 26485712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.
    Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y
    Gene; 2020 Jul; 747():144657. PubMed ID: 32298762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High NUSAP1 expression predicts poor prognosis in colon cancer.
    Liu Z; Guan C; Lu C; Liu Y; Ni R; Xiao M; Bian Z
    Pathol Res Pract; 2018 Jul; 214(7):968-973. PubMed ID: 29853313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy.
    Shi M; Ma F; Liu J; Xing H; Zhu H; Yu J; Yang M
    Breast Cancer Res Treat; 2017 Nov; 166(1):109-116. PubMed ID: 28744749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
    Sharma P; Barlow WE; Godwin AK; Pathak H; Isakova K; Williams D; Timms KM; Hartman AR; Wenstrup RJ; Linden HM; Tripathy D; Hortobagyi GN; Hayes DF
    Ann Oncol; 2018 Mar; 29(3):654-660. PubMed ID: 29293876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients.
    Gui Y; Xu S; Yang X; Gu L; Zhang Z; Luo X; Chen L
    Biomark Med; 2016 Jul; 10(7):771-90. PubMed ID: 27339713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular expression of MTA1, HIF1A and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study.
    Sharaf SS; Jaganath Krishna KM; Lekshmi A; Sujathan
    J Mol Histol; 2024 Jun; 55(3):303-315. PubMed ID: 38613589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer.
    Bolat Kucukzeybek B; Vedat Bayoglu I; Kucukzeybek Y; Alacacioglu A; Yigit S; Akder Sari A; Akyol M; Oktay Tarhan M
    J BUON; 2017; 22(4):947-952. PubMed ID: 28952212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
    Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
    Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
    Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
    Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
    Jiang Y; Liu Y; Tan X; Yu S; Luo J
    Clin Breast Cancer; 2019 Dec; 19(6):450-455. PubMed ID: 31494045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
    Bignon L; Fricker JP; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Caron O; Lortholary A; Faivre L; Lasset C; Mari V; Gesta P; Gladieff L; Hamimi A; Petit T; Velten M
    Breast J; 2018 May; 24(3):269-277. PubMed ID: 28929593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC.
    Ignatov T; Poehlmann A; Ignatov A; Schinlauer A; Costa SD; Roessner A; Kalinski T; Bischoff J
    Breast Cancer Res Treat; 2013 Sep; 141(2):205-12. PubMed ID: 24026861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
    Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers.
    Abdel-Fatah TM; Arora A; Moseley PM; Perry C; Rakha EA; Green AR; Chan SY; Ellis IO; Madhusudan S
    Oncotarget; 2015 Sep; 6(26):21964-78. PubMed ID: 26267318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.